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Exclusive breastfeeding (EBF)—giving infants only breast-
milk (and medications, oral rehydration salts and vitamins 
as needed) with no additional food or drink for their first six 
months of life—is one of the most effective strategies for pre-
venting child mortality1–4. Despite these advantages, only 37% 
of infants under 6 months of age in Africa were exclusively 
breastfed in 20175, and the practice of EBF varies by popula-
tion. Here, we present a fine-scale geospatial analysis of EBF 
prevalence and trends in 49 African countries from 2000–
2017, providing policy-relevant administrative- and national-
level estimates. Previous national-level analyses found that 
most countries will not meet the World Health Organization’s 
Global Nutrition Target of 50% EBF prevalence by 20256. Our 
analyses show that even fewer will achieve this ambition in 
all subnational areas. Our estimates provide the ability to 
visualize subnational EBF variability and identify populations 
in need of additional breastfeeding support.
Previous national-level exclusive breastfeeding (EBF) prevalence 
estimates within Africa4,7,8 found substantial heterogeneity between 
countries, while studies comparing urban and rural locations8,9, 
and subnational-level estimates in select countries8,10,11, also iden-
tified considerable within-country heterogeneity. We found that 
EBF prevalence and trends varied greatly across the African conti-
nent between 2000 and 2017, often irrespective of national or sub-
national boundaries (Fig. 1a–d). The greatest observable patterns 
of improvement, where estimated EBF levels had increased from 
<25% to ≥40% in the modeled period, were along or near the East 
African Rift, including Sudan, South Sudan, Democratic Republic 
of the Congo (DRC), Kenya, Tanzania, Zambia and Malawi. Within 
these countries, an estimated 68 second administrative subdivisions 
(out of 534) had low EBF prevalence (estimates: <25%) in 2000, 
which subsequently increased to meet or exceed the World Health 
Organization’s (WHO’s) Global Nutrition Target (GNT; estimated 
EBF prevalence of ≥50%) by 2017. The estimated national preva-
lence nearly doubled in some countries in western (for example, 
Burkina Faso) and southern (for example, Namibia) sub-Saharan 
Africa (SSA) between 2000 and 2017. This was achieved by reduc-
ing the number of areas with low EBF prevalence. At the same time, 
estimates at higher spatial resolutions highlight corners of persis-
tent need in countries that made notable national progress towards 
EBF targets, including in eastern Angola and eastern and coastal 
areas in South Africa. For example, we estimated a 13.6 percent-
age-point increase (95% uncertainty interval: 8.3–19.6) in national 
EBF prevalence in South Africa, from 10.2% (8.1–12.6%) in 2000 
to 23.8% (18.5–30.0%) in 2017. Yet, areas with persistently lower 
levels, such as the City of Johannesburg (4.9% (2.9–7.7%) in 2000; 
17.4% (10.4–27.0%) in 2017) and throughout Gauteng province 
(5.7% (3.5–8.7%) in 2000; 19.4% (12.0–29.0%) in 2017), contribute 
to South Africa’s relatively low national average.
Figure 1e features the best- and worst-performing locales by 
overlaying the highest- and lowest-prevalence areas (90th and 10th 
percentiles, respectively) across Africa in 2000 and 2017, and areas 
with the highest and lowest weighted annualized rates of change 
(AROC) for the 18-year study period. Burundi and Rwanda—
nearly homogeneously—were among the top achievers in Africa 
in both 2000 and 2017, as were north-western parts of Ethiopia, 
areas scattered throughout Uganda, and south-western Zambia. 
Sudan showed some of the highest and most consistent rates of 
increase within its borders. Areas in southern Côte d’Ivoire, eastern 
and western Burkina Faso, south-western Niger, southern Nigeria, 
northern Central African Republic (CAR), northern Angola, 
southern DRC and central South Africa had among the lowest 
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EBF prevalence in 2000; however, high AROC propelled most of 
these areas out of the lowest decile by 2017. Conversely, areas 
in northern Nigeria and throughout Chad were among the 
lowest-prevalence and lowest-AROC areas, indicating stagnation 
or reversals in progress. The majority of areas in Gabon and 
Somalia, as well as a large geographic area in south-eastern Niger 
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Fig. 1 | EBF prevalence (2000–2017) among infants under 6 months and progress towards the 2025 WHO GNt. a–c, Prevalence of EBF practices at the 
5 km × 5 km resolution in 2000 (a), 2010 (b) and 2017 (c). d, Prevalence of EBF at the first administrative subdivision in 2017. e, Overlapping population-
weighted lowest and highest 10% of grid cells and weighted AROC in EBF from 2000–2017. f, Overlapping population-weighted quartiles of EBF and 
relative 95% uncertainty in 2017. Cut-offs for the quartiles were 25.0% (25th percentile), 38.5% (50th percentile) and 52.3% (75th percentile) for the 
EBF prevalence axis, and 0.500 (25th percentile), 0.902 (50th percentile) and 0.137 (75th percentile) for the relative uncertainty axis (calculated as the 
absolute range of the uncertainty intervals divided by the estimate). g, Weighted annualized percentage change in EBF prevalence from 2000–2017. h, Grid 
cell level prevalence of EBF predicted for 2025, projected from 2017 based on AROC between 2000 and 2017. i, Acceleration in the annualized increase in 
EBF required to meet WHO GNT by 2025. Dark blue pixels were either non-increasing or must accelerate their rate of increase by more than 400% above 
2000–2017 rates during 2017–2025 to achieve the target. White pixels require no increase to meet WHO GNT by 2025. Maps reflect administrative 
boundaries, land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or 
sparsely vegetated’, or were not included in this analysis.
NAtuRE MEDICINE | VOL 25 | AUGUST 2019 | 1205–1212 | www.nature.com/naturemedicine1206
LettersNature MediciNe
and pockets in north-eastern Angola and southern Tunisia, were in 
the lowest-prevalence decile in 2000 and 2017.
Our detailed spatial estimates display broad within-country 
differences throughout Africa that would otherwise be masked 
by national or less granular subnational estimates. ‘Hot spots’ of 
low EBF prevalence are highlighted at higher resolutions (Fig. 2). 
Nationally in 2017, Ethiopia (58.2% (50.4–65.8%)), Tanzania 
(52.6% (46.0–58.9%)), DRC (45.9% (40.0–52.5%)), Kenya (37.6% 
(26.8–49.5%)) and Namibia (40.9% (31.6–50.2%)) were at or 
approaching the 2025 prevalence target (see Fig. 1f for a relative 
uncertainty map). However, some second administrative subdi-
visions in south-eastern Ethiopia and Tanzania with slower EBF 
uptake fell short, and will fail to meet targets based on current 
trajectories (Supplementary Tables 11 and 12), while local-level 
areas in north-eastern Namibia and south-western DRC and Kenya 
were found to have lower prevalence (<25%). Within-country 
disparities in estimated EBF prevalence were both common and 
widespread: in 2017, at least a twofold difference in estimated EBF 
prevalence existed across second administrative subdivisions in 
53.1% (26 of 49) of African countries; at least a threefold difference 
occurred in 14.3% (7 of 49) of countries, and a more than sixfold 
difference was estimated in Niger and Nigeria.
The weighted AROC between 2000 and 2017 (Fig. 1g) and corres-
ponding projected levels of EBF prevalence in 2025 (Fig. 1h) were 
highly variable across the continent, with declines in EBF prevalence 
observed in several countries. In some cases—as in Madagascar—
these decreases occurred against a background of initially high 
EBF prevalence in 2000, and a few central areas are nonetheless 
projected to meet WHO GNT of at least 50% EBF by 2025, assum-
ing that recent trends continue. Although Ethiopia’s north-western 
areas met WHO GNT by 2017, some of these locations experienced 
annualized declines and failed to meet the minimum 1.2% rela-
tive annual increase recommended for well-performing countries6  
(Fig. 3). Following current trajectories, fewer than half of African 
countries (36.7%; 18 of 49) are projected to meet or exceed WHO 
GNT by 2025 based on national-level estimates (Supplementary 
Table 12). Success in meeting WHO GNT in 2025 was predicted for 
all first administrative subdivisions in just eight countries (Burundi, 
Guinea-Bissau, Lesotho, Malawi, Rwanda, São Tomé and Príncipe, 
Sierra Leone and Zambia) and for all second administrative sub-
divisions in just three countries (Guinea-Bissau, Rwanda, and São 
Tomé and Príncipe) (Fig. 3 and Supplementary Table 12).
Many areas will require substantial acceleration of current rates 
of improvement or reversals in trends to meet WHO GNT, includ-
ing much of North Africa and western SSA, and parts of all other 
African regions (Fig. 1i). Given the rates of change we estimated for 
the 2000–2017 period, a band of areas along the Sahel in western 
SSA need an estimated 400% or more increase of existing AROC 
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Fig. 2 | EBF prevalence in 2017 among infants under 6 months at different levels of spatial resolution. a–d, Prevalence of EBF in 2017 at the national (a), 
first administrative subdivision (b), second administrative subdivision (c) and 5 km × 5 km grid cell level (d). Maps reflect administrative boundaries, land 
cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, 
or were not included in this analysis.
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to achieve 50% EBF prevalence by 2025. Most East African Rift 
and bordering countries are on track to achieve targets. Despite 
large gains between 2000 and 2017, and high AROC, reaching 
WHO GNT remains unlikely (<50% probability) by projections 
for some countries, such as in Mali and Côte d’Ivoire (Fig. 4). At 
subnational levels, just 6.3% (412 of 6,499) of second administrative 
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Fig. 3 | Progress towards WHO GNt 2025 during 2013–2017. a–e, Results are shown for 2013 (a), 2014 (b), 2015 (c), 2016 (d) and 2017 (e). Areas in 
purple highlight places that met WHO GNT by achieving at least 50% EBF prevalence. Areas in green highlight locations that achieved a 1.2% annual 
relative increase in addition to meeting WHO GNT of at least 50% EBF prevalence. Maps reflect administrative boundaries, land cover, lakes and 
population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, or were not 
included in this analysis.
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subdivisions across Africa have a high probability (>95%) of 
reaching WHO GNT by 2025, while 43.3% (2,817 of 6,499) were 
almost certain to not reach the target (<5% probability). Local-level 
variation of this probability can be broad; within Senegal, Angola, 
Ethiopia and Tanzania, areas with <5% and areas with >95% prob-
abilities of meeting WHO GNT were estimated. Despite a higher 
probability (>50%) of national achievement to meet the 50% preva-
lence target by 2025, this goal was not within reach in Ethiopia’s 
or Tanzania’s south-eastern areas (<5% probability), indicating 
vulnerable populations left behind in general progress.
These geospatial analyses add to the landscape of mapping 
progress towards nutrition targets and, when compared against 
mapped estimates of conditions associated with infant nutrition, 
can aid in determining where the most at-risk populations are 
located. Many child health conditions are inextricably linked to 
infants’ feeding practices. EBF is associated with reduced incidence 
of diarrhea and pneumonia, and reduced infant mortality rates2. 
Areas with low EBF prevalence and high diarrheal incidence12, 
such as in communities scattered throughout western and central 
SSA and Somalia in 2015 (Extended Data Fig. 1), could benefit 
from increased breastfeeding promotion, education and support. 
Locations with both high infant mortality13 and low EBF prevalence 
(Extended Data Fig. 2), such as in Somalia, and along or near the 
western Sahel in Guinea, Côte d’Ivoire, Nigeria, Chad and CAR 
require urgent attention to improve EBF practices for the greatest 
benefit to child survival.
Our results underscore substantial improvements in EBF 
practices across large geographic areas, as well as disparities both 
between and within countries. Overall, we estimated that only 
18 African countries out of 49 (36.7%) are nationally on track 
to meet WHO GNT by 2025, agreeing with the United Nations 
Children’s Fund (UNICEF) and WHO conclusions that the major-
ity of nations are not on track to achieve nutrition targets8,9. Our 
projections offer the additional capacity to identify which countries 
and areas are predicted to fall short of WHO GNT, with estimates 
disentangled from the tracking of other nutritional targets. Even 
within countries projected to meet WHO GNT, pockets of slow 
uptake remain; only three countries are predicted to reach 50% 
EBF prevalence by 2025 in all second administrative subdivisions, 
and each region had countries with poor-performing areas (<25% 
estimated prevalence). By mapping local-level EBF prevalence and 
trends, we reveal considerable geographic heterogeneity, provide 
a tool to aid decision-makers in visualizing where populations 
with the greatest needs may reside, and allow for the aggregation 
of estimates within meaningful catchment areas or administrative 
levels. When compared against additional data on interventions 
employed, this information could aid in identifying program or 
policy successes and failures.
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Fig. 4 | Probability of meeting WHO GNt for EBF by 2025 at different levels of spatial resolution. a–d, Probability of meeting WHO GNT of at least 50% 
EBF prevalence by 2025 at the national (a), first administrative subdivision (b), second administrative subdivision (c) and 5 km × 5 km grid cell level (d). 
Maps reflect administrative boundaries, land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and 
were classified as ‘barren or sparsely vegetated’, or were not included in this analysis.
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The varied success in implementing national policies—including 
the adoption and enforcement of the International Code of 
Marketing Breast-Milk Substitutes14 (the Code), paid maternity 
leave and breastfeeding-related workplace programs15, and the 
Baby-Friendly Hospital Initiative (BFHI)16—may contribute to 
variation in EBF levels across Africa. In 1973, the publication of 
The Baby Killer, an exposé on the manipulative marketing tac-
tics used by some breast-milk substitute (BMS) companies, raised 
widespread alarm17. Controversial BMS promotion strategies, such 
as free samples and dressing saleswomen as nurses, may have 
led to increased usage and dependence on unaffordable formula 
products lacking the nutritional and immunological benefits 
of breast-milk, and the exposure of infants to increased risks of 
pathogens and mortality17. In 1981, the Code14 was created at the 
World Health Assembly to encourage breastfeeding and regula-
tion of the safety and promotion of alternatives. However, as of 
2018, only 12 African countries have comprehensive legislation 
on the Code, and 17 of 47 have no legal measures in place to pro-
tect consumers from aggressive BMS marketing18. Even with pro-
visions enacted into national law, active monitoring systems and 
implementation may be weak or inadequate, yet evidence suggests 
that more restrictive policies may be associated with less pervasive 
promotion of unnecessary BMS usage19,20. Additional legislation 
and more thorough enforcement of existing legislation is needed 
in some countries.
Maternal protection policies—such as onsite child care, physical 
areas for breastfeeding or pumping and storing breast-milk, and 
paid maternity leave policies—offer additional support and auto-
nomy to mothers working outside the home who may otherwise 
turn to BMS19,21–23. The International Labour Organization advo-
cates for legislation requiring 14 weeks of paid maternity leave to 
support breastfeeding by working mothers9. Additionally, a recent 
analysis across 38 low- and middle-income countries found a signif-
icant and positive association between a 1-month increase in legis-
lated maternity leave and a 5.9 percentage-point difference in EBF15. 
A study in Ghana showed that working mothers with shorter mater-
nity leave were less likely to practice EBF24. In 2018, however, only 
ten African countries met the basic provisions of maternity leave25.
BFHI is a WHO- and UNICEF-led effort to ensure that all 
hospital-based and free-standing maternity units are breastfeed-
ing support centers16. ‘Baby friendly’-designated facilities do not 
accept free or low-cost BMS, and implement ten steps for success-
ful breastfeeding—a package of clinical practices and management 
procedures that have been demonstrated to improve EBF rates26. 
While the majority of African countries have adopted BFHI, only 
two have reported more than 50% implementation of the ten steps 
across their facilities25. Many have reported 0% implementation 
or have not assessed facilities in the past 5 years, suggesting that 
the initiative has become dormant9,25. As with any program, BFHI 
delivery efficiency varies across space and time; thus, local-level 
monitoring to gauge progress is needed.
Many of EBF’s primary barriers involve cultural perceptions and 
misinformation, which can be highly variable across communities, 
contributing to local variation in EBF practices and the need for 
community-based interventions. Women’s perceptions of insuffi-
cient breast-milk, beliefs about infant thirst and need for water, and 
the cultural and family norms that support the early introduction 
of food and liquid are a few examples of barriers that vary broadly 
across communities21–23,27. Mothers who perceive their breast-
milk to be nutritionally inadequate are more likely to discontinue 
EBF22. In many settings, mothers’ early breast-milk (colostrum) 
is considered sour and difficult to digest, and is discarded and 
replaced by prelacteal feeding of water, formula or animal milk, 
making it difficult to establish breastfeeding21–23. The early intro-
duction of water and porridges is common practice across the conti-
nent23,28, inhibiting EBF practice and exposing infants to disease and 
nutritional risks from pathogens; plain water is the greatest obstacle 
in the western and central regions28, and women along the Sahel 
have cited the high heat index as a reason for feeding their infants 
water23. Generational feeding practices are passed on, and mothers 
can be influenced by community and family members’ attitudes 
towards breastfeeding23,28,29.
Although pervasive, the aforementioned issues can be addressed 
through lactation management, breastfeeding support, and social 
and behavior-change communication approaches27. Through inten-
sive home-based support or participatory women’s groups, health 
workers can dispel breastfeeding myths, increase confidence and 
equip mothers with the necessary skills to address breastfeeding 
issues, including infant suckling difficulties or pain22. A study in 
Ghana showed that women who received infant feeding recommen-
dations from health workers were more likely to practice EBF24. An 
integrated approach combining promotion, counseling and educa-
tion on EBF in communities and health facilities has been found to 
be significantly more effective than counselling as a single interven-
tion29. In a systematic review of 46 studies, all forms of extra breast-
feeding support—including face-to-face or telephone interactions 
by professional or lay support staff—led to a decrease in EBF ces-
sation (risk ratio 0.88 (0.85–0.92)) when analyzed together30. As of 
2018, however, only 18 of the 49 African countries in our analyses 
offered community-based breastfeeding programs in all of their 
districts, and 21 report offering individual infant and young child 
feeding counselling in all of their primary health care facilities25; no 
information on the quality of services or number of women reached 
by these programs is available9. Funding for such interventions is 
limited, as only 17 African countries currently receive at least US$2 
per birth towards breastfeeding programs25.
Government buy-in and combined approaches are key to 
increasing the likelihood of success of community-based programs. 
The Alive & Thrive Initiative has shown that improving EBF is 
possible at scale through a combination of advocacy, interpersonal 
communication, community mobilization and mass media21,31. In 
Ghana and Madagascar, EBF rates significantly improved when 
training, as well as social and behavior-change activities, were deliv-
ered via partnerships between government and non-governmental 
organizations27. Furthermore, a meta-analysis found that combin-
ing health system, home and community-based approaches was 
most effective at improving EBF rates29. Impact evaluations of 
similar community-based projects with health systems integration 
in Ethiopia, Kenya and Senegal found EBF counselling from both 
facility-based and community personnel to significantly increase 
the odds (odds ratio = 2.90; P < 0.001) of EBF32.
It is difficult to interpret EBF trends in Africa without consider-
ing the human immunodeficiency virus (HIV) epidemic and the 
impact that evolving recommendations may have had on infant 
feeding practices in high-burden countries. In 1997, WHO was 
advising HIV-infected mothers to avoid breastfeeding—to pre-
vent mother-to-child transmission—if replacement feeding could 
be practised safely33. However, several studies in the early 2000s 
reported lower HIV transmission risk among exclusively breastfed 
infants compared with those who were mixed-fed (that is, breastfed 
and given solid foods or infant formula)34–36. These studies, coupled 
with subsequent research indicating the efficacy of antiretrovi-
ral therapy (ART)37, led to new guidance in 2010 in favor of EBF 
for children of HIV-infected women on ART38—a recommenda-
tion reiterated in 201639. These changing recommendations may 
have contributed to low initial EBF rates in 2000 and subsequent 
improvements through 2017 in some countries, particularly in east-
ern and southern SSA, where HIV prevalence is high and access to 
HIV testing, counselling and ART increased during the 2000–2017 
period. Continued access to HIV treatment, along with support for 
breastfeeding in high-burden areas, are urgent priorities to further 
EBF and optimize maternal and child health40.
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Widely considered one of the most effective behaviors in prevent-
ing child mortality, and a key component of WHO’s Global Action 
Plan for the Prevention and Control of Pneumonia and Diarrhoea1, 
EBF can save and improve the quality of lives3. While facilities may 
be collecting data on breastfeeding interventions and EBF rates for 
monitoring purposes in some locations, improved data collection 
efforts are needed across many African locales, and the estimates 
here are supplemental to those efforts. The EBF estimates presented 
here, at various spatial resolutions, can assist public health practi-
tioners and policymakers in visualizing and identifying disparities 
across and within countries—informing decisions on where exist-
ing interventions and policies may need to be bolstered, or new 
strategies considered, to ensure that all infants have the opportunity 
to survive and thrive.
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Methods
Overview. Our analyses provide annual estimates of EBF prevalence among 
infants under 6 months of age during the period of 2000–2017 across Africa 
at the national, first and second administrative (for example, state and district 
level, respectively), and 5 km × 5 km grid cell levels. EBF prevalence is defined 
as the proportion of children who receive only breast-milk, oral rehydration 
salts or other medicines or vitamins, without receiving additional food or drink 
(including water) between birth and 6 months of age. Our primary goal was to 
provide prevalence predictions at a high spatial resolution across the African 
continent with the best out-of-sample predictive performance. The methodology 
used here is similar to that used for previous analyses of diarrhea incidence12, 
under 5 years mortality13, child growth failure41, educational attainment42 and 
HIV43 in Africa. We first mapped our estimates on a 5 km × 5 km grid to remain 
consistent with these previous analyses, align with the resolutions available for 
pre-existing covariates incorporated in these analyses, and maintain flexibility in 
aggregating these estimates to other levels of interest (for example, first and second 
administrative subdivisions). Our analyses of 49 countries include mainland Africa 
and the islands of Madagascar, Comoros, and São Tomé and Príncipe. We do not 
provide estimates for Libya, Djibouti or island nations where survey data were not 
available (Mauritius, Seychelles and Cape Verde). This study follows the Guidelines 
for Accurate and Transparent Health Estimates Reporting (http://gather-statement.
org; Supplementary Table 1).
Data extraction and processing. Extended Data Fig. 3a describes the detailed 
steps performed during the data extraction and data processing workflow. We 
extracted data from the Demographic and Health Surveys (DHS) program, 
UNICEF's Multiple Indicator Cluster Surveys (MICS), and country-specific 
and other multinational surveys conducted in the years 1998–2017 for African 
countries. Though we model estimates for the years 2000 to 2017, we assigned data 
from 14 surveys in the years 1998–1999 to the year 2000 to address data scaricity in 
earlier years and to help establish a baseline. We searched the Global Health Data 
Exchange (GHDx: http://ghdx.healthdata.org/) for all surveys in African countries 
tagged as containing EBF indicators of interest; designed and tested a codebook, 
or survey data extraction framework, for breastfeeding variables present in the 
household surveys; extracted and geo-matched (either to geospatial coordinates 
or administrative subdivisions) all surveys available for Africa; and refreshed our 
query of the GHDx for surveys performed in African countries.
Data inclusion and exclusion criteria. As our goal was to estimate the prevalence 
of EBF among infants under 6 months of age, we only included data regarding 
the feeding of children less than 6 months old at the time of survey (0–5 months 
in survey data). Specifically, our inclusion criteria for survey microdata (that is, 
surveys with individual-level responses) were the following: (1) the survey must 
have been conducted in an African country between 1998 and 2017; (2) survey 
responses must be available at the individual level; (3) the survey must contain 
subnational geographic identifiers, which could include either subnational areal 
units (typically administrative subdivisions) or Global Positioning System (GPS) 
coordinates, and data referenced to subnational units must also contain survey 
weights for each observation; and (4) the survey must contain questions about the 
age of the child, whether the child is still being breastfed and whether the child 
has consumed other food or liquid items. Typically, consumption during the past 
24 h was recorded. In eight out of 181 surveys with microdata, the question about 
food or liquid items did not specify a particular recall period. After performing 
sensitivity analysis, we decided to keep those eight surveys in our model. In 
cases where survey microdata were not available, we searched for survey report 
estimates. Our inclusion criteria for these survey reports were the following:  
(1) the survey must have been conducted in an African country between 1998 and 
2017; (2) the survey must contain subnational identifiers, which could include 
subnational areal units (typically administrative subdivisions); and (3) the survey 
must contain the prevalence of EBF, with a sample size or the lower and upper 
bounds for the 95% confidence interval.
Very few surveys directly asked about EBF practice; as such, we derived 
breastfeeding status from questions asking about the consumption of breast-milk 
and other foods, liquids and medicines consumed in a set period before the survey, 
typically within the 24-h period before survey completion. We excluded surveys 
that only asked mothers and caregivers whether infants had been exclusively 
breastfed (for example, ‘did you exclusively breastfeed?’) without ascertaining 
further information. This exclusion criterion was established after finding, by 
comparing the responses in surveys containing both types of questions, that 
many mothers and caregivers stated that infants had exclusively breastfed but also 
answered that they had received food or water in the 24-h recall questions. This 
may have been due to the respondent misunderstanding the meaning of ‘exclusive 
breastfeeding’, or the question may have been misinterpreted with translation. 
Instead, we classified children as exclusively breastfed if survey responses indicated 
that they received only breast-milk and medicines (oral rehydration salts, vitamins 
or other medicines) without other foods or liquids during the 24-h period before 
the survey.
To identify potential survey biases, we reviewed national-level survey estimates 
for each country and compared them with national-level estimates from the DHS 
program, the 2017 Global Burden of Disease (GBD) study5 and the geospatial 
model. In cases where a survey’s estimates appeared implausible compared with 
other existing survey-based data sources, we inspected differences in definitions, 
data collection or other methodological explanations.
Identified data sources. As a result, we identified and used 188 household surveys 
that had complete records of questions relating to infant feeding and geographical 
information; 102 were from the DHS series, 79 were from the MICS series and 
seven were from other sources. Extended Data Fig. 4 shows the spatial and 
temporal extent of data availability by country, and Supplementary Tables 2 and 3 
provide information on the names, citations and geographic detail of surveys of  
the underlying data sources of our models.
Supplementary Table 4 provides a list of surveys that were excluded from both 
the geostatistical model and GBD 2017 estimates5. Supplementary Table 5 provides 
a list of surveys that were included in the geostatistical model but excluded from 
the GBD estimates (in cases where surveys were non-nationally representative but 
could provide spatial information for the geostatistical model). Supplementary 
Table 6 provides a list of surveys that were included in GBD estimates but  
excluded from the geostatistical model.
Data processing. After data identification and extraction, we aggregated the 
individual-level responses from survey microdata to calculate EBF prevalence 
and the effective sample size at the finest possible spatial resolution available, 
incorporating individual-level sample weights and using the Kish approximation44 
for the effective sample size. Each individual child record was associated with 
a cluster, a group of neighboring households or a ‘village’ that acts as a primary 
sampling unit (a census enumeration area). For surveys where a latitude and 
longitude pair representing the location of each survey cluster were available 
(‘point data’), data were aggregated to these specific coordinates. Geographic 
coordinates or place names for each cluster were included in 101 surveys  
(33,341 clusters).
In the case of survey microdata where geographical coordinates were not 
available and in the case of survey reports, we assigned data to the smallest 
available administrative unit in the survey (‘polygon data’)45. We ‘resampled’ data 
matched to polygons to generate pseudo-point data based on the underlying 
population distribution within the polygon. The methods for resampling were 
consistent with those previously used in geospatial modeling of under 5 years 
mortality13. Specifically, for each polygon-level observation, we randomly 
sampled 10,000 locations among grid cells in the given polygon with probability 
proportional to grid cell population. A grid cell was assigned to a polygon if its 
centroid fell within the geographic boundary. We performed k-means clustering 
(with k set to 1 per 40 grid cells) on the sampled points to generate a reduced set  
of locations to be used in modeling based on the k-means cluster centroids. 
Weights were assigned to each pseudo-point proportional to the number of 
sampled points contained in each of the k-means clusters (that is, the number of 
sampled points divided by 10,000). Each pseudo-point generated by this process 
was assigned the EBF prevalence and sample size observed for the polygon as a 
whole, and the weights associated with each pseudo-point were applied during  
all stages of model fitting.
After performing the data processing described above, our final dataset 
consisted of 60,083 clusters (33,341 of which were GPS-located data points  
and 26,742 of which were polygon data) from 188 surveys (181 surveys with 
microdata and seven survey reports) representing 153,465 children across 49 
African countries.
Statistical analysis. Covariates. In these analyses, we included the following 
socioeconomic, environmental and health-related covariates to improve the 
predictions of EBF: urbanicity, night-time lights, travel time to the nearest 
settlement with >50,000 inhabitants, total population, human development index 
(HDI), educational attainment in women of reproductive age (15–49 years old), 
nutritional yield for vitamin A, and HIV prevalence. These covariates were selected 
because they are factors or proxies for factors that previous literature has identified 
to be associated (not necessarily causally) with EBF prevalence.
The first four covariates were included as measures or proxies for 
connectedness and urbanicity, as EBF is typically found to be different in urban 
areas compared with rural locations. HDI—a composite indicator of key aspects 
of development (namely, education, economy and health)—was chosen based on 
previous studies relating country development to EBF. Educational attainment 
in women of reproductive age (15–49 years old) was included because previous 
studies highlight education as a maternal factor influencing the decision to initiate 
and continue EBF. Nutritional yield for vitamin A was chosen as a proxy of 
maternal nutrition while breastfeeding. HIV was included given the known risks 
of mother-to-child transmission of HIV and consequent potential avoidance of 
breastfeeding in hyper-endemic settings over the study period. These covariates 
underwent spatial and temporal processing in preparation for their inclusion in 
analysis. See Supplementary Table 7 for references to the covariate data used in the 
models, as well as references supporting our rationale for using these covariates.
Spatial processing involved resampling the input covariate raster to align the 
spatial resolution of the covariate to the 5 km × 5 km resolution used in modeling. 
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For covariates that were originally at a finer resolution, we resampled the raster 
by taking the neighborhood average (that is, for the covariates ‘travel time to 
the nearest settlement of >50,000 inhabitants’ and ‘night-time lights’) or using 
the nearest neighbor (that is, for the covariate ‘urbanicity’) or sum (that is, for 
the covariate ‘total population’) of the finer covariate raster to produce one at a 
5 km × 5 km resolution. Educational attainment in women of reproductive age and 
HIV covariates were produced at a 5 km × 5 km resolution in our previous studies, 
and thus did not require additional spatial processing. For covariates that were 
originally at lower resolutions (that is, the covariates ‘HDI’ and ‘nutritional yield 
for vitamin A’), we resampled the raster using bilinear interpolation, with the effect 
of smoothing some of the hard pixel boundaries in the raw data to make for a 
5-km × 5-km-resolution raster.
Temporal processing was required in instances where the original temporal 
resolution of the covariate was anything other than annual. To resolve from a 
coarser time period to an annual time period, we filled the intervening years 
with the value from the nearest neighboring year (that is, for the covariate 
‘urbanicity’) or used an exponential growth rate model (that is, for the covariate 
‘total population’). Night-time lights, educational attainment and HIV prevalence 
were available at a 1-year temporal resolution and did not require interpolation. 
As the travel time to the nearest settlement of >50,000 inhabitants and nutritional 
yield for vitamin A covariates were available only for a single representative year 
(2015 and 2005, respectively), these covariates were set to be unchanged over time. 
After interpolation, the covariates of night-time lights, HDI and urbanicity were 
still missing information for the most recent years of the 2000–2017 period, and in 
these instances we filled out the end of the time series carrying forward the most 
recent year without modification.
We list detailed information on the temporal resolution and source(s) for each 
of the eight included covariates in Supplementary Table 7. In addition, the calendar 
year was used as a covariate in our model. See Extended Data Fig. 5 for maps of 
spatial covariate raster layers for 2017.
Spatial covariate stacking. Our primary goal was to provide prevalence predictions 
across the African continent at a high resolution, and we used methods designed 
to provide the best out-of-sample predictive performance at the cost of inferential 
understanding. An ensemble covariate modeling method was implemented to both 
select covariates and capture possible nonlinear effects and complex interactions 
between them46. We fit separate models for five African regions based on the 
geographical regions defined for the GBD47 (central, eastern, northern, southern 
or western, as seen in Extended Data Fig. 3b). For each region, three submodels 
were fitted to our dataset, using all of our covariate data as explanatory predictors: 
generalized additive models, boosted regression trees and lasso regression. We 
selected these three submodels based on the ease of implementation through 
existing software packages, the fundamental differences in their approaches and 
a proven track record in predictive accuracy46. Submodels were fit in R using the 
mgcv, xgboost, glmnet and caret packages.
Each submodel was fit using fivefold cross-validation to avoid overfitting, and 
hyper-parameter fitting was performed to maximize the predictive power. For 
each submodel, we produced two sets of predictions: out of sample and in sample. 
Out-of-sample predictions for each model were generated by compiling the 
predictions from the five holdouts from each cross-validation fold, and in-sample 
predictions were generated by refitting the submodels using all available data. The 
out-of-sample submodel predictions were used as explanatory covariates when 
fitting the geostatistical model described below, and the in-sample predictions 
were used when generating predictions from the geostatistical model, to maximize 
data use. In both cases, the logit transformation of the predictions was used to 
put these predictions on the same scale as the linear predictor in the geostatistical 
model. Maps of in-sample predictions from each stacker are presented in Extended 
Data Fig. 6. A recent study has shown that this ensemble approach can improve 
predictive validity by up to 25% over an individual model46.
Geostatistical model. As a second step, we fit the geostatistical model below 
separately for the five African regions. For each region, we write the hierarchy that 
defines our Bayesian model as follows:
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We modeled the number of children who were categorized as ‘exclusively 
breastfed’ (EBFi) among a sample size (Ni) at space–time location (i) as a binomial 
random variable. The logit-transformed prevalence of EBF (pi) was specified as a 
linear combination of a regional intercept (β0), the logit-transformed predictions 
from the three submodels (Xi), country-level random effects (γci), a correlated 
spatiotemporal error term (ϵ iGP ) and an independent and identically distributed 
nugget (uncorrelated error term) effect ϵ( )i . Weighting coefficients (β) were 
constrained to sum to 1 (ref. 46). The spatial covariance (Σspace) was modeled using 
an isotropic and stationary Matérn function48. The temporal covariance (Σtime) was 
an annual first-order autoregressive function.
The intercept captures the overall mean level of EBF prevalence, while the 
covariate effects capture the spatial and temporal variation in EBF prevalence that 
can be described as a function of spatial and temporal variation in the included 
covariates. The country random effects capture additional variation between 
countries. Spatially and temporally correlated random effects capture additional 
variation by location (within and between countries) and time. Finally, the 
uncorrelated error term (or nugget effect) captures any additional, non-structured 
variation by location and time.
The Matérn covariance function is associated with two hyper-parameters,  
κ and τ (ν is fixed at 1), while a temporal first-order autoregressive (AR1) covariance 
function is associated with one hyper-parameter, ρ. The following hyper-priors 
were set for each of these parameters:
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The prior for the temporal correlation parameter, ρ, corresponds to a mean 
of 0.96 and a distribution that is wide enough to include approximately 0.2 to 1.0 
within three standard deviations of the mean. This relatively informative prior was 
chosen because temporal correlation was expected to be high. μθ1, σθ1, μθ2 and σθ2 were automatically determined by integrated nested Laplace approximation (INLA). Priors for fixed effects and hyper-priors for other random effects were  
set as:
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This model was fit in R-INLA49 using the stochastic partial differential 
equations50 approach to approximate the continuous spatiotemporal Gaussian 
random fields ϵ( )iGP . We constructed a finite-elements mesh for the stochastic 
partial differential equations approximation to the Gaussian process regression 
using a simplified polygon boundary (as seen in Supplementary Fig. 12 of our 
previous publication of geospatial estimates of child growth failure41). We set the 
inner mesh triangle maximum edge length (the mesh size for areas over land) to 
be 0.25 decimal degrees, and the buffer maximum edge length (the mesh size for 
areas over the ocean) to be 5.0 decimal degrees. Fitted model parameters are listed 
in Supplementary Table 8.
After fitting each model based on regional classification, we generated 1,000 
draws of all model parameters from the approximated joint posterior distribution 
using the inla.posterior.sample() function in R-INLA. For each draw, s, of the 
model parameters, we constructed a draw of pi
s( ) as:
β β γ ϵ ϵ= + + + +−p Xlogit ( )i
s s
i
s
ci
s
i
s
i
s( ) 1
0
( ) ( ) ( )
GP
( ) ( )
Additional processing of the output from inla.posterior.sample() is required for 
the correlated spatiotemporal error term ϵ( )isGP( )  and the nugget effect ϵ( )i s( )  before 
constructing pi
s( ) according to the equation above. Specifically, for ϵ isGP( ) , draws are 
generated initially only at the vertices of the finite element mesh, so we project 
from this mesh to each location i desired for prediction (that is, the centroid of 
each grid cell on a 5 km × 5 km grid, as well as years from 2000–2017). For the 
nugget effect, we generate ϵi s( ) for each i by sampling from normal σ(0, )snug2 ( ) . At the 
end of this process, we have 1,000 draws of pi for each grid cell and year.
Model validation. Validation strategy. We used fivefold cross-validation to assess 
the performance of the modeling framework described above. To do so, we first 
split all survey data into five groups by randomly sorting a list of unique identifiers 
for each survey, calculating the cumulative effective sample size represented by the 
surveys in this list, and then dividing the list into five parts at the point where this 
cumulative sample size was closest to 20, 40, 60 and 80% of the total. This resulted 
in five groups that were approximately equal in terms of the total effective sample 
size, and which contained entire surveys (that is, all of the data points derived 
from each survey were contained exclusively within only one fold). We then fit the 
model described above five times, excluding each of the five groups of data in turn.
After fitting the model five times, the data withheld from each model were 
matched with predictions from that model, and then these data–prediction pairs 
were compiled across all five models, resulting in a complete dataset of out-of-
sample predictions corresponding to all survey data included in the analysis. EBF 
prevalence estimates based on single survey clusters are generally quite noisy due 
to very small sample sizes, and were consequently insufficient as a ‘gold standard’ 
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for evaluating the model predictions13. To address this issue, we aggregated both 
the observed data and the corresponding out-of-sample predictions within 
countries and within first- and second-level administrative subdivisions, by 
calculating a weighted mean of each using the effective sample sizes as the weights. 
Then, across all data–estimate pairs, we calculated two summary measures: the 
mean error (a measure of bias) and the root-mean-square error (RMSE; a measure 
of total variance). In addition, for each data–estimate pair, we constructed 95% 
prediction intervals from the 2.5th and 97.5th percentiles of 1,000 draws from a 
binomial distribution corresponding to each of the 1,000 posterior draws of EBF 
prevalence, with p equal to EBF prevalence in a given posterior draw and N equal 
to the effective sample size for the data point type. We then calculated coverage as 
the percentage of data–estimate pairs where the data point was contained within 
this 95% prediction interval.
Sensitivity analyses. To assess the utility of the stacking ensemble, we ran five 
fivefold cross-validation holdout experiments, using different combinations of 
covariates and random effects. The following five models were compared:
 (1) raw covariates:
β β γ ϵ= + + +p Xlogit( )i i ci i0 raw
 (2) stacking predictions as covariates:
β β γ ϵ= + + +p Xlogit( )i i ci i0 stack
 (3) a Gaussian process:
β γ ϵ ϵ= + + +plogit( )i ci i0 GPi
 (4) raw covariates + a Gaussian process:
β β γ ϵ ϵ= + + + +p Xlogit( )i i ci i0 raw GPi
 (5) stacking covariates + a Gaussian process (final model):
β β γ ϵ ϵ= + + + +p Xlogit( ) i ci ii 0 stack GPi
Supplementary Table 9 compares the results of this cross-validation exercise 
in terms of the performance of these five different modeling strategies, and 
Extended Data Fig. 7 provides a comparison of the estimates derived from these 
different models. At all three levels of aggregation, and both in and out of sample, 
mean error (bias) is relatively low, ranging from −0.49 to 0.42 percentage points. 
Out-of-sample RMSE is relatively similar for all five models, while in sample, 
model 1 (raw covariates only) has noticeably worse RMSE compared with the 
other models. Overall, model 5 (a two-stage model including stacked regression 
for the covariates) has the lowest out-of-sample RMSE value across three levels of 
aggregation. The coverage of the 95% prediction intervals showed that the models 
with a Gaussian process (models 3, 4 and 5) outperformed those without (models 1 
and 2). For all models with a Gaussian process, coverage of the prediction intervals 
was close to 98% in sample, and between 88 and 92% out of sample. From the 
results of these sensitivity analyses, we chose model 5: a two-stage model including 
stacked regression for the covariates.
Additionally, to assess the impact of including surveys that do not explicitly 
state a 24-h recall period in questions asking about food and liquid given to a child, 
we considered models with and without the data included from those surveys. 
Supplementary Table 9 also compares the cross-validation performance of the 
two models: one containing only surveys that specify a 24-h recall period; and 
one containing all available surveys. Both in-sample and out-of-sample metrics 
are reasonably comparable across these two models. Since the model that includes 
all surveys does not produce additional bias or underestimate the degree of 
uncertainty (there were only eight out of 188 surveys that did not specify 24 h as a 
recall period), we chose to keep all surveys (Extended Data Fig. 8).
Post-estimation. To take advantage of the extensive data gathering and analysis of 
GBD 20175, which in some cases included data sources outside of the scope of our 
geospatial modeling framework, we performed post-hoc calibration of our estimates 
to the GBD estimates5 (please refer to Supplementary Tables 2, 3 and 6 for the data 
sources used). First, each grid cell in our 5 km × 5 km grid was assigned to a GBD 
geography based on the location of the grid cell centroid. Then, for each country 
and year, we defined a raking factor that was the ratio of the GBD estimate for this 
geography and year to the population-weighted posterior mean EBF prevalence 
across all grid cells within this geography and year. Finally, this raking factor 
was used to scale each draw of EBF prevalence for each grid cell within the GBD 
geography and year. The corresponding mean raking factor across all countries 
was 0.96 (interquartile range: 0.82–1.08), indicating close agreement with GBD 
estimates. National time series plots of the post-GBD calibration final estimates 
(including uncertainty ranges) are presented along with the aggregated input data 
(classified by survey series, data type and sample size) in Extended Data Fig. 9.
After calibration to GBD 20175, grid cell level estimates were aggregated to the 
second administrative subdivision, first administrative subdivision and national 
levels using population-weighted averages at the draw level. This was carried out 
for each of the 1,000 posterior draws (after calibration to GBD 20175, as described 
above), and then point estimates and uncertainty intervals were derived from the 
mean, 2.5th percentile and 97.5th percentile of these draws, respectively. In cases 
where an administrative subdivision did not contain the centroid of any grid cell, 
the nearest grid cell to it was assigned as its proxy prevalence.
Since the publication of GBD 20175, recently released survey microdata 
(Senegal 2017, Sierra Leone 2017 and South Africa 2016) and additional survey 
reports (Algeria 2006, Burkina Faso 2012, Burkina Faso 2016, Mali 2016, Niger 
2009, São Tomé and Príncipe 2006, and Somalia 2009) were incorporated to update 
GBD 2017 estimates using GBD 2017 methods5. These updated GBD estimates 
were used for calibrating our estimates. For additional information on the names, 
citations and geographic details of these surveys, see Supplementary Tables 2 and 3 
(records are marked with a single asterisk).
Although our models can predict for all locations covered by available raster 
covariates, we applied a mask on barren areas based on Moderate Resolution 
Imaging Spectroradiometer satellite data51. All maps in our figures reflect 
administrative boundaries, land cover, lakes and population. Gray-colored grid 
cells represent areas with fewer than ten people per 1 km × 1 km grid cell, and were 
classified as ‘barren or sparsely vegetated’, or were not included in this analysis51–55. 
This step was intended to be useful to policy planners and data specialists.
Projections. We compared our estimated rates of improvement in EBF prevalence 
over the past 18 years with the improvements needed between 2017 and 2025 
to meet WHO GNT (50% EBF prevalence)6 by performing a simple projection 
calculation. First, we calculated log-additive AROC at each grid cell (i) by logit-
transforming our 18 years of posterior mean prevalence, previ
l
,year
 and calculating 
the AROC between each pair of adjacent years starting with 2001:
= − −AROC prev previ
l
i
l
i
l
,year ,year ,year 1
We then calculated a weighted AROC for each pixel by taking a weighted 
average across the years, where more recent AROC were given more weight in the 
average. We defined the weights to be:
= −
∑ −
γ
γw
year
year
( 2000)
( 2000)year 2001
2017
where γ may be chosen to give varying amounts of weight across the years. For 
this set of projections, we selected γ = 1, resulting in a linear weighting scheme 
that has been tested and vetted for use in projecting the health-related Sustainable 
Development Goal)56. For any grid cell, we then calculated the weighted AROC  
to be:
∑=AROC w AROCi year il2001
2017
,year
Finally, we calculated the projections by applying the weighted AROC at each 
grid cell to our 2017 posterior mean prevalence:
= + ×−Proj prev AROClogit ( 8)i i
l
i j,2025
1
,2017 ,
We used the same process to project country- and administrative-level AROC. 
This projection scheme was analogous to the methods used in the GBD 2017 
measurement of progress and projected attainment of health-related Sustainable 
Development Goals56.
Limitations. Data availability. This work should be assessed in full 
acknowledgment of the data and methodological limitations. Most importantly, 
the accuracy of our estimates is critically dependent on the quantity and quality 
of the underlying data. The availability of relevant data varied both spatially and 
temporally across Africa (Extended Data Fig. 4), and the lack of relevant data is 
one of the main sources of uncertainty around our estimates (as seen in Fig. 1f). 
We have constructed a large database of geo-located EBF prevalence data for the 
purposes of this analysis; nonetheless, important gaps in data coverage—both 
spatial and temporal—remain. More local data are necessary to monitor health 
outcomes and guide quality improvement efforts, and to increase the certainty 
of our results. Collecting local data from all communities every year would be 
an insurmountable task for most countries; this study aids in filling the current 
knowledge gap by producing estimates for areas without data collection based on 
learned patterns from well-surveyed areas, using the same estimation methods for 
all areas for comparable results across communities.
Data accuracy. In addition, there are several factors related to data quality that 
should be acknowledged. Data in our analyses were obtained from caregivers 
of infants at any time point between birth and 6 months of age. Although an 
infant’s EBF status was based on a single time point (the 24 h preceding the survey 
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interview), which is known to overestimate EBF practice for the full 6-month 
period, as infants may be fed other foods and liquids either before or after the 
survey, this estimation is standard practice57,58. Following the standard approach 
for estimating EBF based on international guidelines57,58, the proportion of infants 
who are exclusively breastfed for the full 6 months is calculated by estimating the 
prevalence of EBF for all children under 6 months of age (though EBF is known to 
decline with age)57. Due to the age range (0- to 5-month-old infants) relevant to the 
purpose of estimating EBF prevalence, our sample sizes are relatively smaller than 
previous efforts mapping localized estimates for health conditions, outcomes and 
socioeconomic indicators12,13,41,42, further contributing to the relatively large degree 
of uncertainty associated with our estimates.
The location information associated with the data compiled for these analyses 
is subject to some error. To protect respondents’ confidentiality, most surveys 
that collect GPS coordinates perform some type of random displacement on 
those coordinates before releasing data for secondary analyses. For example, 
GPS coordinates for DHS data are displaced by up to 2 km for urban clusters, 
up to 5 km for most rural clusters, and up to 10 km in a random 1% of rural 
clusters59. Furthermore, data associated with polygons rather than GPS coordinates 
were resampled so that they could be included in the geostatistical model, 
but this process essentially assumes that EBF prevalence is constant over the 
polygon. Research on scalable methods for better integration of polygon data in 
geostatistical models similar to those used in this analysis is currently ongoing.
Modeling limitations. With respect to the modeling strategy, the primary limitation 
is the difficulty in assessing model performance at the grid cell level. We used 
cross-validation to assess model performance but, due to the substantial impact of 
sampling error on estimates derived from single survey clusters, it was necessary 
to aggregate both the data and predictions when assessing error. Additionally, 
while we attempted to propagate uncertainty from various sources through the 
different modeling stages, there are some sources of uncertainty that have not 
been propagated. In particular, it was not computationally feasible to propagate 
uncertainty from the submodels in stacking through the geostatistical model. 
Similarly, although the WorldPop population raster is also composed of estimates 
associated with some uncertainty, this uncertainty is difficult to quantify and not 
currently reported, and so we were unable to propagate this uncertainty into our 
estimates of EBF prevalence for administrative subdivisions that were created using 
population-weighted averages of grid cell estimates.
Model fitting was carried out using an integrated nested Laplace approximation 
to the posterior distribution, as implemented in the R-INLA package49. Prediction 
from fitted models was subsequently carried out using the inla.posterior.sample() 
function, which generates samples from the approximated posterior of the fitted 
model. Both model fitting and prediction thus require approximations, and these 
approximations may introduce error. While it is difficult to assess the impact of 
these approximations in this particular use case, our validation analyses found that 
our final model has low bias and good coverage of the 95% prediction intervals, 
which provides some reassurance that the approximation method used, as well 
as other potential sources of error, are not resulting in appreciable bias or poorly 
described uncertainty in our reported estimates.
Furthermore, our projection methods are derived from the previous 
spatiotemporal historical trends and based on the assumption that recent trends 
will continue; thus, we are not projecting underlying drivers (such as increasing 
urbanization or changes in population)60.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The findings of this study are supported by data that are available in public online 
repositories, data that are publicly available on request from the data provider, 
and data that are not publicly available due to restrictions by the data provider and 
which were used under license for the current study (including select data sources 
in Botswana, Eritrea, Ghana, Kenya, South Africa and Zambia, as indicated in 
Supplementary Tables 2 and 10). Detailed data sources can be found in Supplementary 
Tables 2–6 and 10. More information about each data source is available on the GHDx 
(http://ghdx.healthdata.org/), including information about the data provider and links 
to where the data can be accessed or requested (where available).
Administrative boundaries were retrieved from the Global Administrative  
Unit Layers dataset, implemented by the FAO within the CountrySTAT and 
Agricultural Market Information System projects52. Land cover was retrieved from 
the online Data Pool, courtesy of the NASA EOSDIS Land Processes Distributed 
Active Archive Center, USGS/Earth Resources Observation and Science Center, 
Sioux Falls, South Dakota51. Lakes were retrieved from the Global Lakes and 
Wetlands Database, courtesy of the World Wildlife Fund and the Center for 
Environmental Systems Research, University of Kassel53. Populations were retrieved 
from WorldPop55.
Outputs of these EBF analyses at national, administrative and 5 km × 5 km levels 
throughout Africa are publicly available at the GHDx (http://ghdx.healthdata.
org/record/ihme-data/africa-exclusive-breastfeeding-prevalence-geospatial-
estimates-2000-2017) and can be explored through our customized visualization 
tools (https://vizhub.healthdata.org/lbd/ebf).
EBF estimates, at various spatial levels, can be explored using custom online data 
visualization tools (http://vizhub.healthdata.org/lbd/ebf), and are publicly available 
at the GHDx (http://ghdx.healthdata.org/record/ihme-data/africa-exclusive-
breastfeeding-prevalence-geospatial-estimates-2000-2017). The data that support 
the findings of this study are available on the GHDx; however, some of these data 
were used under licenses for the current study and are not publically available. All 
data sources are indicated in Supplementary Table 2, and data with restrictions are 
indicated with an obelisk symbol.
Code availability
Our study follows the Guidelines for Accurate and Transparent Health Estimates 
Reporting (Supplementary Table 1). All code used for these analyses is publicly 
available online at https://github.com/ihmeuw/lbd/tree/ebf-africa-2019.
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Extended Data Fig. 1 | Comparison of diarrhea prevalence in children under 5 years and EBF prevalence by area. Overlapping population-weighted 
tertiles of diarrhea prevalence (in children under 5 years)12 and EBF prevalence (in children 0–5 months) in 2000, 2005, 2010 and 2015. Cut-offs for the 
tertiles were 20.8 and 36.1% for the EBF prevalence axis, and 3.6 and 5.0% for the diarrhea prevalence axis. Maps reflect administrative boundaries, land 
cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, 
or were not included in this analysis.
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Extended Data Fig. 2 | Comparison of risk of death (age 0–11 months) and EBF prevalence by area. Overlapping population-weighted tertiles of  
mortality risk (in children 0–11 months)13 and EBF prevalence (in children 0–5 months) in 2000, 2005, 2010 and 2015. Cut-offs for the tertiles were 
20.8 and 36.1% for the EBF prevalence axis, and 4.3 and 6.4% for the risk of death axis. Maps reflect administrative boundaries, land cover, lakes and 
population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, or were not 
included in this analysis.
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Extended Data Fig. 3 | Analytic process overview and map of modeling regions. a, The process used to produce EBF prevalence estimates in Africa 
involved three main parts. In the data-processing steps (peach), data were identified, extracted and prepared for use in the model. In the modeling phase 
(orange), we used these data and covariates in a stacked generalization ensemble model and spatiotemporal Gaussian process model. In post-processing 
(red), we calibrated the prevalence estimates to match GBD 20175 estimates and aggregated the estimates to the first- and second-level administrative 
subdivisions in each country. b, Modeling regions were defined as the five GBD regions for Africa: central (central SSA), east (eastern SSA), north (North 
Africa and the Middle East), south (southern SSA) and west (western SSA). As this study was limited to mainland Africa and African island nations 
(except Mauritius, Seychelles, Cape Verde Islands, Libya and Djibouti, where relevant data were not available or did not meet our inclusion and exclusion 
criteria), Middle East countries were excluded (Afghanistan, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, 
Turkey, United Arab Emirates and Yemen).
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Extended Data Fig. 4 | Data availability for EBF among infants under 6 months by type and country, 1998–2017. a, EBF data used in this study, by region 
and country. Color indicates the data source: DHS; MICS; or other survey type. Shape type indicates whether a data source has point (GPS) or polygon 
(for example, aggregated to an administrative level) location information. Size indicates the relative effective sample size for each source. A full list of data 
sources, with additional details about data type (such as survey microdata and survey reports) and geographical details, is provided in Supplementary 
Tables 2 and 3. b, Maps of EBF data coverage displayed at 5-year intervals. Maps show the spatial resolution of the underlying data in our models, and the 
color indicates the EBF prevalence as estimated from the data sources. Countries in white have no available survey data in the given time range.
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Extended Data Fig. 5 | Map of covariates. Covariate raster layers of possible socioeconomic, environmental and health-related covariates used as inputs 
for the stacking modeling process. Time-varying covariates are presented for the year 2017. For additional detail on the year of production of non-time-
varying covariates, see the individual covariate citation in Supplementary Table 7. Maps reflect administrative boundaries, land cover, lakes and population; 
gray-colored grid cells had fewer than ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, or were not included in this 
analysis.
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Extended Data Fig. 6 | Maps of in-sample predictions from the ensemble covariate modeling process. a–c, Each map represents the in-sample predicted 
prevalence of EBF generated from the three submodels: (a) a generalized additive model; (b) a boosted regression trees model; and (c) lasso regression, 
for 2000. Maps reflect administrative boundaries, land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid 
cell and were classified as ‘barren or sparsely vegetated’, or were not included in this analysis.
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Extended Data Fig. 7 | see figure caption on next page.
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Extended Data Fig. 7 | Predictions comparison from the covariate sensitivity analysis. a–e, EBF prevalence among infants under 6 months in 2017 at 
the 5 km × 5 km grid cell level, based on models with no covariates and including: a Gaussian process (a); raw covariates with no Gaussian process (b); 
raw covariates with a Gaussian process (c); stacked covariates with no Gaussian process (d) and stacked covariates with a Gaussian process (e; the final 
model). Estimates are shown without calibration to GBD 20175, to better highlight the differences between the models (that would have been masked after 
calibration). Maps reflect administrative boundaries, land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 km × 1 km grid 
cell and were classified as ‘barren or sparsely vegetated’, or were not included in this analysis.
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Extended Data Fig. 8 | Predictions comparison from the recall period sensitivity analysis. a,b, EBF prevalence among infants under 6 months in 2000 
at the 5 km × 5 km grid cell level, based on models containing only surveys that specify a 24-h recall period (a) and containing all available surveys (b). 
Estimates are shown after calibration to GBD 20175, to better highlight the differences between the final maps when the models include all surveys or only 
surveys that specify a 24-h recall period. Maps reflect administrative boundaries, land cover, lakes and population; gray-colored grid cells had fewer than 
ten people per 1 km × 1 km grid cell and were classified as ‘barren or sparsely vegetated’, or were not included in this analysis.
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Extended Data Fig. 9 | National time series plots and aggregated input data. National time series plots of the post-GBD calibration final estimates by 
country during 2000–2017. Uncertainty ranges are presented in gray, and aggregated input data are classified by survey series (purple, country specific; 
green, DHS; yellow, MICS), data type (square, polygon; circle, point) and whether the survey is nationally or subnationally representative. A list of 
subnationlly representative surveys in given in Supplementary Table 10.
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Data analysis These analyses were carried out using R version 3.5.0. The main geostatistical models were fit using R-INLA version 18.07.12. All code 
used for these analyses is publicly available online at https://github.com/ihmeuw/lbd/tree/ebf-africa-2019. 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The findings of this study are supported by data that are available in public online repositories, data that are publicly available upon request from the data provider, 
and data that are not publicly available due to restrictions by the data provider and which were used under license for the current study. Detailed tables of data 
sources can be found in Supplementary Tables 2-6. More information about each data source is available on the Global Health Data Exchange (http://
ghdx.healthdata.org/), including information about the data provider and links to where the data can be accessed or requested (where available).  
 
Administrative boundaries were retrieved from the Global Administrative Unit Layers (GAUL) dataset, implemented by FAO within the CountrySTAT and Agricultural 
Market Information System (AMIS) projects [52]. Land cover was retrieved from the online Data Pool, courtesy of the NASA EOSDIS Land Processes Distributed 
Active Archive Center (LP DAAC), USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, South Dakota [51]. Lakes were retrieved from the 
Global Lakes and Wetlands Database (GLWD), courtesy of the World Wildlife Fund and the Center for Environmental Systems Research, University of Kassel [53]. 
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Populations were retrieved from WorldPop [55]. 
 
All estimates produced as part of these analyses are publicly available from the Global Health Data Exchange (http://ghdx.healthdata.org/record/ihme-data/africa-
exclusive-breastfeeding-prevalence-geospatial-estimates-2000-2017) and via a user-friendly data visualisation tool (https://vizhub.healthdata.org/lbd/ebf).   
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size was calculated as the number of unique data source-location pairs with survey responses regarding the feeding of children less 
than 6 months old at the time of the survey, in order to estimate exclusive breastfeeding (EBF) prevalence). This sample size is reported in the 
methods section: "After performing the data processing described above, our final dataset consisted of 60,083 clusters (33,341 of which were 
GPS-located data point and 26,742 of which were polygon data) from 188 surveys (181 surveys with microdata and 7 survey reports) 
representing 153,465 children across 49 African countries." This is an observational study with no hypothesis testing and the sample size was 
not pre-specified. We evaluate the overall performance of our modelling strategy, given the available data, as part of a validation exercise as 
described in the 'Model validation' section of the methods, and as reported in the Supplementary Information (Supplementary Table 9).
Data exclusions Surveys or reports that did not contain the relevant variable (i.e., survey responses regarding the feeding practices of children less than 6 
months old at the time of the survey) or did not contain subnational geographic detail or could otherwise not be geolocated, or were outside 
the geographic (i.e., Africa) or temporal (i.e., 1998-2017) scope of the study, were excluded as not relevant for these analyses. Surveys with 
microdata (i.e., individual-level responses) were excluded if they did not contain questions about the age of the child, whether the child is still 
being breastfed, and whether the child has consumed other food or liquid items. Survey reports without microdata were excluded if the 
survey did not contain a prevalence number for EBF with a sample size or the lower and upper bounds for the 95% confidence interval. 
Additionally, we excluded surveys that only asked mothers and caregivers if infants had been exclusively breastfed (e.g., "did you exclusively 
breastfeed?") without ascertaining further information. This exclusion criterion was established after finding, by comparing responses in 
surveys containing both types of questions, that many mothers and caregivers stated infants had exclusively breastfed but also answered that 
they had received food or water in the 24-hour recall questions. This may be due to the respondent misunderstanding the meaning of 
"exclusive breastfeeding" or the question may have been misinterpreted with translation. Instead, we classified children as exclusively 
breastfed if survey responses indicated they received only breast-milk and medicines (i.e., oral rehydration salts, vitamins, or other medicines) 
without other foods or liquids on the 24-hour period prior to the survey.    
Replication This is an observational study using many years of survey and report data and in principle could be replicated. Due to the time required to 
extract, process, and geo-locate all data, as well as to run the statistical models, we have not undertaken an explicit replication analysis.
Randomization Randomization was not relevant to this study. This analysis is an observational mapping study and there were no experimental groups.
Blinding Blinding was not relevant to this study, as it was an observational study using survey and report data. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
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